The investment from Immortal Dragons marks a significant step forward in advancing Etheros Pharmaceuticals’ fullerene-derived therapeutic programme. By targeting oxidative stress, a fundamental driver ...

“Etheros represents an investment in a differentiated platform addressing oxidative stress through catalytic antioxidants,” Boyang Wang, founder of Immortal Dragons, said in the press release (1).

Electrochemically converting carbon dioxide into value-added chemicals, such as carbon monoxide for producing synthetic fuels, is a challenge the research sector continues to tackle. However, many ...

Researchers from the University of Tsukuba in Japan have discovered the properties that enhance the efficiency of tin-based perovskite solar cells. It is a breakthrough that could revolutionize the ...

LipoFullerene TM has been highly reputed as a raw material for anti-aging cosmetics, and it has been renewed. VC60 spent almost 5 years to develop the natural-derived Fullerene, which is then stably ...

Denka has acquired a 50% stake in the fullerene maker Frontier Carbon from Mitsubishi Corporation. Frontier, founded in Japan in 2001, supplies C60, C70, and higher-order fullerenes and blends.

Fullerenes have fascinated chemists for decades—with the discoverers of the all-carbon version C 60 even nabbing the 1996 Nobel Prize in Chemistry. Chemists have also tried to make these cagey ...

An international team of researchers has successfully observed and understood the formation of fullerenes in the universe using the Swiss SLS synchrotron light source at PSI. Researchers confirmed the ...